Holen Sie sich die Stockscreener-App
130.51
0.73%
0.95
Vorhandelsmarkt:
131.50
0.99
+0.76%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Why Illumina Inc. (ILU) stock stays on buy listsSwing Trade & Real-Time Sentiment Analysis - DonanımHaber
Will Illumina Inc. stock outperform international peersWeekly Investment Report & Expert Verified Movement Alerts - Улправда
Is Illumina Inc. stock supported by innovation pipelineWeekly Trading Summary & Real-Time Price Movement Reports - Улправда
Why hedge funds are buying Illumina Inc. stock2025 Volume Leaders & Momentum Based Trading Ideas - Улправда
“It can’t wait until tomorrow”: How patient advocacy drives change - Illumina
Is Illumina Inc. stock undervalued vs historical averagesQuarterly Risk Review & Community Trade Idea Sharing Platform - Улправда
DNA/Gene Microarray Market Growth Potential Examined Through - openPR.com
Illumina, Inc. $ILMN Shares Acquired by Aaron Wealth Advisors LLC - MarketBeat
Illumina Inc (NASDAQ:ILMN) Nasdaq Futures Shape Discovery Market Now - Kalkine Media
Discipline and Rules-Based Execution in ILMN Response - news.stocktradersdaily.com
Illumina Target of Unusually Large Options Trading (NASDAQ:ILMN) - MarketBeat
How AstraZeneca improved their genomics processing to be 60% faster, 70% more cost-effective - Amazon Web Services
Sicart Associates LLC Has $7.89 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat
Scott Davies Sells 323 Shares of Illumina (NASDAQ:ILMN) Stock - MarketBeat
Illumina To Webcast Upcoming Investor Conference - Yahoo Finance
Meet three scientists behind Illumina’s spatial assay breakthrough - Illumina
Santa Rally Looms: These 5 Stocks Often Deliver Gifts To Investors - Benzinga
Gene Prediction Tool Industry Report 2025: Precision Genomics, - openPR.com
JP Morgan Maintains Illumina (ILMN) Neutral Recommendation - Nasdaq
Illumina (NASDAQ:ILMN) Given New $130.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Twists, tangles, and transcription: Does epigenetics play a role in Alzheimer's? - Illumina
Thrivent Financial for Lutherans Purchases 684,802 Shares of Illumina, Inc. $ILMN - MarketBeat
United States DNA Sequencing Market 2031 | Growth Drivers, Key - openPR.com
Illumina, Inc. $ILMN Shares Bought by Neuberger Berman Group LLC - MarketBeat
Marex Group plc Makes New $1.24 Million Investment in Illumina, Inc. $ILMN - MarketBeat
NGS Based RNA Sequencing Market is growing at a CAGR of 19.7%, - openPR.com
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually - PR Newswire
Illumina’s AI Genomics Partnership With MyOme Might Change The Case For Investing In Illumina (ILMN) - Sahm
Nikko Asset Management Americas Inc. Increases Stake in Illumina, Inc. $ILMN - MarketBeat
AQR Capital Management LLC Raises Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
4D Advisors LLC Purchases Shares of 30,000 Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Using genomic testing to deliver hope to families - Illumina
DNA Computing Market - GlobeNewswire Inc.
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Maple Rock Capital Partners Inc. Sells 26,145 Shares of Illumina, Inc. $ILMN - MarketBeat
Ilex Capital Partners UK LLP Raises Stock Position in Illumina, Inc. $ILMN - MarketBeat
Ieq Capital LLC Buys 176,611 Shares of Illumina, Inc. $ILMN - MarketBeat
Your lab’s new best friend for scalable proteomics: Illumina Protein Prep - Illumina
Illumina invests in MyOme to advance AI-driven genomic health models By Investing.com - Investing.com India
Illumina (NASDAQ: ILMN) invests in MyOme to launch AI-driven WGS trial in 2026 - Stock Titan
Illumina, Inc. $ILMN Shares Acquired by Natixis - MarketBeat
California Public Employees Retirement System Purchases 17,439 Shares of Illumina, Inc. $ILMN - MarketBeat
Stifel reiterates Buy rating on Illumina stock, cites multiple growth levers - Investing.com Australia
Amundi Has $35.14 Million Stake in Illumina, Inc. $ILMN - MarketBeat
Leadership Perspectives: Illumina leads the industry in genomic AI - Illumina
Does Surging Genomics Consumables Demand Reshape The Bull Case For Illumina’s Recurring Revenue Engine (ILMN)? - Yahoo Finance
Invesco Ltd. Buys 444,543 Shares of Illumina, Inc. $ILMN - MarketBeat
Norges Bank Buys Shares of 239,640 Illumina, Inc. $ILMN - MarketBeat
Zacks.com featured highlights include Illumina, Commercial Metals and Newmont - Yahoo Finance
Precision oncology at your community’s doorstep - Illumina
First Trust Advisors LP Purchases 185,830 Shares of Illumina, Inc. $ILMN - MarketBeat
How Illumina’s (ILMN) Analyst Earnings Upgrade Will Impact Investors - Sahm
1832 Asset Management L.P. Makes New Investment in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Shares Purchased by Arrowstreet Capital Limited Partnership - MarketBeat
Illumina Inc ILU Stock Analysis and ForecastAI-Driven Market Analysis & Free Lightning Fast Capital Gains - earlytimes.in
Brown Advisory Inc. Has $69.27 Million Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina (ILMN): Assessing Valuation After a Quiet Share Price Rebound - Yahoo Finance
Illumina (NASDAQ:ILMN) Upgraded at Zacks Research - MarketBeat
Illumina at the 2025 China International Import Expo (CIIE) - Illumina
Will Illumina Inc. (ILU) stock draw ESG focused funds2025 Top Decliners & Smart Swing Trading Techniques - Newser
How Illumina Inc. (ILU) stock reacts to fiscal policiesPortfolio Risk Report & Weekly Chart Analysis and Trade Guides - Newser
AI in Biotech Market Is Booming Worldwide | NVIDIA, Illumina - openPR.com
Epigenetics Market size to reach $8.63 Billion by 2035 | Key - openPR.com
American Century Companies Inc. Sells 32,763 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina (ILMN) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance
Schroder Investment Management Group Raises Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Will Illumina Inc. (ILU) stock keep high P E multiplesTrade Signal Summary & Safe Capital Allocation Plans - Newser
Can Illumina Inc. (ILU) stock sustain revenue momentumJuly 2025 Setups & Entry Point Confirmation Signals - Newser
1.48%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):